Analysis of:
Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented At AAN (www.medicalnewstoday.com)
Ideal treatment of Multiple Sclerosis is still ongoing. Interferons are only partially succesful in treating this condition. Alemtuzumab, a drug that was intended for the treatment of B-cell chronic lymphocytic leukemia proved to be useful in MS. It reduced significantly the risk of relapse and...
Analysis of:
Major phase 3 program planned for new antiplatelet drug (www.theheart.org)
(1) TRA-SCH 530348 has a novel mechanism of action. (2) Many antiplatelet agents (and anticoagulation therapies) are available with differences based on ability to prevent clotting and risk of systemic hemorrhage. (3) Unclear what the benefits or risks of new agents will be until assessed in controlled...
Analysis of:
Research Finds Newer Drug for Partial Epilepsy Is Superior But Old Tops New For Generalised Seizures (www.medicalnewstoday.com)
The article reports on a British study suggesting that lamotrigine and valproic acid are respectively the best first line drugs for partial and generalized onset epilepsy.
Analysis of:
Avicena Announces Patient Enrollment in National Institutes Of Health (NIH) Phase III Parkinson's Disease Trial (www.medicalnewstoday.com)
PD-02 is an ultra-pure form of creatine which may slow the progress of Parkinson’s Disease. A federal government sponsored phase III clinical trial has just begun to evaluate its efficacy.
Analysis of:
Suffering boomers want to fill Vioxx void (www.contracostatimes.com)
The article states that Cox-2 inhibitors may be making a comeback to treat arthritis pain
Analysis of:
FDA Approves Duloxetine for Anxiety (journals.elsevierhealth.com)
Duloxetine has received FDA approval for the treatment of generalized anxiety disorder, based on the results of three studies of more than 800 subjects.
Analysis of:
Study Compares Benefits Of Surgical Treatments For Degenerative Spinal Disease - Higher Success Rates Shown In Procedures Using Plate System (www.medicalnewstoday.com)
This article reports on a meta-analysis comparing different surgical procedures for cervical fusion. Approaches with anterior plating provided the highest rates of fusion.
Analysis of:
MIT Brace Aids Stroke Recovery - Worn On The Arm, NeuroRobotic Device Is Lightweight, Portable (www.medicalnewstoday.com)
A new robotic brace developed by MIT researchers allows patients to have improved limb use by facilitating joint movement.
Analysis of:
Vaccines: What Does Cervical Cancer Have To Do With Chickenpox? (blogs.wsj.com)
The article discusses current problems with the apparent short life of the chicken pox vaccine and mandatory vaccinations.
Analysis of:
Wal-Mart And Partners Create Health-IT Research Center (informationweek.com)
Wal-Mart has teamed with the University of Arkansas and Blue Cross Blue Shield to create a new health IT research center
Its goals are to reduce medical errors and increase the efficiency of health care supply.